Our gastroenterology product portfolio is not only dedicated to the advanced diagnosis of gut-related diseases such as inflammatory bowel disease or pancreatic insufficiency but also perfectly suited for the prevention of gut-related diseases such as colon cancer.

The ELISA tests are suited for single plate or medium-high-throughput analysis on automated readers. Below, you can find the markers and their diagnostic relevance at a glance.

Biomarkers for clinical diagnostics

Biological markers (biomarkers) are measurable indicators for specific conditions. The following biomarkers are relevant in gastroenterology:

  • Calprotectin is a highly specific indicator of gastrointestinal inflammation which is used for differentiation of IBD and IBS and for treatment monitoring.
  • α1-antitrypsin and sIgA indicate the integrity of the gut wall. This is relevant for monitoring and diagnosing the leaky gut syndrome.
  • Pancreatic elastase is used for the detection of pancreatic insufficiency and pancreatitis.

Therapeutic drug monitoring

Therapeutic drug monitoring of Infliximab (IFX, Remicade®) and Adalimumab (Humira®) supports the optimization of treatment and reduction of treatment costs.


You can find more information on our test kit portfolio for gastroenterology in our free customer brochures:

You might also be interested in

The RIDASCREEN® UST Monitoring is an enzyme linked immunosorbent assay intended for the quantitative determination of ustekinumab (UST, Stelara®) i...
RIDASCREEN® GLM Monitoring is an enzyme linked immunoassay intended for the quantitative determination of golimumab (GLM, Simponi®) in human serum ...
RIDA®QUICK ADM Monitoring C...
For in vitro diagnostic use. The RIDA®QUICK ADM Monitoring Control Set is intended for the use with the corresponding, batch specific kit RIDA®QUIC...

Gastroenterology support

Questions? Tap into our team’s expertise. We’re here to support you and your business throughout the testing process to ensure your success

Start typing and press Enter to search